✦ LIBER ✦

Pulmonary function in hemophiliac patients treated with commercial factor VIII concentrates

✍ Scribed by Juan Chediak; Alan Chausow; Anne Solarski; Margaret C. Telfer

Book ID: 115680151
Publisher: Elsevier Science
Year: 1984
Tongue: English
Weight: 392 KB
Volume: 77
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(84)90705-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abnormal B-cell function in hemophiliacs

Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates

✍ Andrew Gorski; George F. Gjerset; Paul J. Martin; Richard B. Counts; John A. Han 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 579 KB

In vitro reactivity of factor VIII inhib

In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates

✍ Giuseppe Tagariello; Daniela Zanotto; Paolo Radossi; Roberto Sartori; Donata Bel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

Delayed cutaneous hypersensitivity react

Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate

✍ Doreen B. Brettler; Ann D. Forsberg; Frank Brewster; John L. Sullivan; Peter H. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 618 KB

Incidence of inhibitors in patients with

Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentrates

✍ Dr. Iise Schwarzinger; Ingrid Pabinger; Christian Korninger; Ferdinand Haschke; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 2 views

Porcine factor VIII and plasmapheresis i

Porcine factor VIII and plasmapheresis in the management of hemophiliac patients with inhibitors

✍ Dr. Robert D. Bona; Dominick N. Pasquale; Robert I. Kalish; Barbara A. Witter 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

Prevalence of HTLV-IIVLAV antibodies in

Prevalence of HTLV-IIVLAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX

✍ Paola Verani; Guglielmo Mariani; Pier M. Mannucci; Giulio de Rossi; Loredana Nic 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

The prevalence of HTLV-III/LAV antibodies was evaluated in 222 Italian asymptomatic hemophiliacs treated exclusively with commercial factor concentrates made with American plasma. An increase of HTLV-III/LAV seropositivity from 1983 to 1985 was evident. This was independent of the type of hemophilia